Stephen J. Kent - Concepedia

Author

Stephen J. Kent

Also Known As

Adam K Wheatley, Alisiarr J. Raima, Amy W. Chung, Anthony D. Kelleher, Damian F. J. Purcell, Damian F.J. Purcell, Deborah A. Williamson, Ivan Stratov, J. Kent, Joanna R. Groom

557

Publications

26.7K

Citations

H-Index

152

Concepts

All Affiliations

The University of Melbourne Peter Doherty Institute Monash University Melbourne Sexual Health Centre UNSW Sydney

About

Stephen J. Kent is an author at The University of Melbourne specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	126	11.5K
2	Engineering	15	17	971
3	Allergy	13	14	616
4	Public Health	8	8	281
5	Natural Sciences	4	4	89

Stephen J. Kent

264

Publications

19.9K

Citations

H-Index

Page 1

	Year	Citations
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection David S. Khoury, Deborah Cromer, Arnold Reynaldi, Nature Medicine Humoral ResponseImmunologyAntiviral ResponseHumoral ImmunityImmune Protection	2021	4.1K
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection Chansavath Phetsouphanh, D.R. Darley, Daniel B. Wilson, Nature Immunology Viral PersistenceCovid-19 PandemicImmunologyImmunologic DiseaseChronic Viral Infection	2022	939
Long-lived epithelial immunity by tissue-resident memory T (T <sub>RM</sub> ) cells in the absence of persisting local antigen presentation Laura K. Mackay, Angus T. Stock, Z. Joel, Proceedings of the National Academy of Sciences	2012	635
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19 Jennifer A. Juno, Hyon‐Xhi Tan, Wen Shi Lee, Nature Medicine Adaptive Immune SystemHumoral ResponseImmunologyHumoral ImmunityCd4 T Cell Responses	2020	476
Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells Marc Rigau, Simone Ostrouska, Thomas S. Fulford, Science	2020	407
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19 Adam K. Wheatley, Jennifer A. Juno, Jing Jing Wang, Nature Communications	2021	400
Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus Stephen J. Kent, Anne Zhao, Susan J. Best, Journal of Virology	1998	325
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine Yi Ju, Wen Shi Lee, Emily H. Pilkington, ACS Nano	2022	294
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface Sandhya Bangaru, Shanshan Lang, Michael Schotsaert, Cell ImmunologyVirologyInfluenza VaccineFlu VaccinationVirus Transmission	2019	255
Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans Henry J. Sutton, Racheal Aye, Azza H. Idris, Cell Reports	2021	227

Page 1